Abbott Laboratories (ABT)

84.32
-2.69 (-3.09%)
NYSE · Last Trade: May 10th, 6:42 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close87.01
Open87.15
Bid84.33
Ask84.45
Day's Range84.08 - 87.31
52 Week Range84.08 - 139.06
Volume10,913,509
Market Cap147.64B
PE Ratio (TTM)22.61
EPS (TTM)3.7
Dividend & Yield2.520 (2.99%)
1 Month Average Volume13,644,943

Chart

About Abbott Laboratories (ABT)

Abbott Laboratories is a global healthcare company that specializes in the development of a wide range of medical devices, diagnostics, nutrition products, and pharmaceuticals. The company focuses on innovation to improve patient outcomes and enhance the quality of life for individuals worldwide. Abbott is known for its advancements in areas such as cardiovascular care, diabetes management, and nutrition science, providing essential tools and solutions that support healthcare professionals and patients in managing various health conditions. With a strong commitment to research and development, Abbott continually seeks to address unmet medical needs and contribute to the advancement of healthcare globally. Read More

News & Press Releases

What This Fund’s $4 Million Apollo Commercial Real Estate Finance Sale Could Signal About CRE Riskfool.com
This mortgage REIT generates income by originating and managing commercial real estate loans across the United States.
Via The Motley Fool · May 10, 2026
What to Know About This Fund’s $3 Million Blackstone Mortgage Trust Sale Amid Office Stressfool.com
Blackstone Mortgage Trust originates senior commercial real estate loans globally, generating income primarily from interest and dividends.
Via The Motley Fool · May 10, 2026
Abbott Laboratories (NYSE:ABT) Presents a Decent Value Opportunity After 21% Pullbackchartmill.com
Via Chartmill · May 8, 2026
Safer Dividend King to Buy Now: AbbVie or Johnson & Johnson?fool.com
They have combined for 118 years of consecutive dividend increases.
Via The Motley Fool · May 6, 2026
Got $5,000? These 3 High-Yielding Stocks Are Trading Near Their 52-Week Lowsfool.com
These stocks pay more than double the S&P 500 average and have modest valuations relative to the overall market.
Via The Motley Fool · May 6, 2026
Want Reliable Dividend Income in May? These 2 Stocks Deliverfool.com
These stocks check off multiple boxes for income investors.
Via The Motley Fool · May 6, 2026
This Dividend King's Yield Hasn't Been This High in a Decade. Is It a Buy?fool.com
A rare yield, Dividend King status, and a steady healthcare business may be creating one of its most interesting income setups in years.
Via The Motley Fool · May 3, 2026
1 Magnificent Dividend Stock Down 30% to Buy and Hold Foreverfool.com
This company, which has raised its dividend for 54 consecutive years, is on sale.
Via The Motley Fool · May 2, 2026
AbbVie Fires Healthy Trend-Following Signal: Is a Rebound Ahead?marketbeat.com
Via MarketBeat · April 29, 2026
How to Pick a Healthcare Stock That Can Weather Any Marketfool.com
How does a nearly 3% (and growing) dividend yield sound?
Via The Motley Fool · April 28, 2026
This Boring Dividend King Might Be the Safest Pick to Add to Your Portfolio
Abbott Labs is a balance of income and growth.
Via Barchart.com · April 23, 2026
Better Medical Device Stock Right Now: Abbott Laboratories vs. Dexcomfool.com
They offer investors very different value propositions.
Via The Motley Fool · April 20, 2026
Market Crash: 2 Healthcare Stocks Worth Loading Up on at a Discountfool.com
Various concerns weighed on appetite for stocks in recent weeks.
Via The Motley Fool · April 20, 2026
The Best High-Yield Dividend Stocks to Buy for 2026 and Beyondfool.com
These stocks pay juicy dividends but also offer much more.
Via The Motley Fool · April 19, 2026
Abbott Stock Crash: Rebound Could Be Coming Fastmarketbeat.com
Via MarketBeat · April 17, 2026
Abbott Laboratories Analysts Slash Their Forecasts After Q1 Earningsbenzinga.com
Abbott Laboratories (NYSE:ABT) reported upbeat Q1 earnings but lowered its 2026 outlook, including dilution from Exact Sciences acquisition.
Via Benzinga · April 17, 2026
TSMC's Chip Heat Extends the Record Run, Then Netflix Drops a Double Surprise After the Bellchartmill.com
Via Chartmill · April 17, 2026
Why Abbott Laboratories Stock Tumbled on Thursdayfool.com
It essentially met analyst expectations for its inaugural quarter of 2026.
Via The Motley Fool · April 16, 2026
3 Healthcare Stocks That Have Held Up in Every Market Downturnfool.com
Johnson & Johnson, Abbott Laboratories, and Becton, Dickinson don't fall as far as other healthcare stocks and bounce back faster during economic downturns.
Via The Motley Fool · April 16, 2026
Which S&P500 stocks are moving on Thursday?chartmill.com
Via Chartmill · April 16, 2026
Discover which S&P500 stocks are making waves on Thursday.chartmill.com
Via Chartmill · April 16, 2026
Abbott (ABT) Q1 2026 Earnings Call Transcriptfool.com
Abbott (ABT) Q1 2026 Earnings Call Transcript
Via The Motley Fool · April 16, 2026
What's going on in today's session: S&P500 gap up and gap down stockschartmill.com
Via Chartmill · April 16, 2026
Abbott Laboratories’s (NYSE:ABT) Q1 CY2026 Sales Top Estimates
Healthcare product and device company Abbott Laboratories (NYSE:ABT) announced better-than-expected revenue in Q1 CY2026, with sales up 7.8% year on year to ...
Via StockStory · April 16, 2026
Which S&P500 stocks are moving before the opening bell on Thursday?chartmill.com
Via Chartmill · April 16, 2026